{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-079248","form_type":"8-K","ticker":"ANVS","cik":"0001477845","company_name":"Annovis Bio, Inc.","filed_at":"2025-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.074628+00:00","generated_at":"2026-05-17T12:23:13.736251+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Annovis Bio CFO resigns; CEO Maccecchini appointed acting CFO","bullets":["Andrew Walsh resigned as VP of Finance and Principal Financial Officer, effective Aug 22, 2025.","Resignation was not due to any disagreement with the company's operations, policies, or practices.","CEO Maria Maccecchini appointed Acting CFO effective Aug 15, 2025, by unanimous board vote.","Company has begun actively searching for a permanent Chief Financial Officer."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-079248","json":"https://secwatch.observer/filing/0001104659-25-079248.json","markdown":"https://secwatch.observer/filing/0001104659-25-079248.md","text":"https://secwatch.observer/filing/0001104659-25-079248.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925079248/0001104659-25-079248-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925079248/tm2523187d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T12:23:13.736251+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}